Given that blood samples from patients with obesity were not always collected on days 3–5 of the menstrual cycle, the objective comparison of FSH, LH, and estradiol hormone levels was not possible due to their cycle sensitivity. This evidence concerns the gene BRD2 and obesity due to melanocortin 4 receptor deficiency.